Endovascular thrombectomy: Time is still brain

The "Time is brain" concept should be familiar to anyone who cares for patients with acute ischemic stroke. IV tissue plasminogen activator (tPA) reduces disability after stroke when administered within 4.5 hours of symptom onset, but the benefit of IV tPA is time-dependent.1 Earlier treatment improves functional outcomes. Quantified many ways, studies provide estimates in terms of functional outcome at 90 days, neurons saved, and days of disability-free life gained.1–3 As a result, door-to-needle time, defined as the time from hospital arrival to the initiation of IV tPA, has become an important quality metric for stroke hospitals around the world.
Source: Neurology - Category: Neurology Authors: Tags: Outcome research, Quality of life, All Cerebrovascular disease/Stroke, Models of care, Infarction EDITORIALS Source Type: research